Emerging role of the cannabinoid receptor CB 2 in immune regulation: therapeutic prospects for neuroinflammation

The capsaicin receptor: a heat-activated ion channel in the pain pathway

Caterina, M. J., Schumacher, M. A., Tominaga, M., Rosen, T. A., Levine, J. D., & Julius, D. J. (1997) · Nature · doi:10.1038/39807 · Cited by 9,132 · see citing works

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633 · see citing works

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · see citing works

Microglia: a sensor for pathological events in the CNS

Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · see citing works

Cell Migration: A Physically Integrated Molecular Process

Lauffenburger, D. A., & Horwitz, A. F. (1996) · Cell · doi:10.1016/s0092-8674(00)81280-5 · Cited by 3,915 · see citing works

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · see citing works

The many roles of chemokines and chemokine receptors in inflammation

Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · see citing works

Cannabinoid receptor localization in brain.

Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321 · see citing works

Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.

Baggiolini, M., Dewald, B., & Moser, B. (1994) · PubMed · Cited by 2,232 · see citing works

Human Chemokines: An Update

Baggiolini, M., Dewald, B., & Moser, B. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.675 · Cited by 2,193 · see citing works

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142 · see citing works

Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations

Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D. J., Fur, G. L., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,751 · see citing works

lnterleukin-8 and Related Chemotactic Cytokines—CXC and CC Chemokines

Baggiolini, M., Dewald, B., & Moser, B. (1993) · Advances in immunology · doi:10.1016/s0065-2776(08)60509-x · Cited by 1,672 · see citing works

The Cell Biology of Macrophage Activation

Adams, D. O., & Hamilton, T. A. (1984) · Annual Review of Immunology · doi:10.1146/annurev.iy.02.040184.001435 · Cited by 1,611 · see citing works

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

Marzo, V. D., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,585 · see citing works

The orphan receptor GPR55 is a novel cannabinoid receptor

Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568 · see citing works

Actin-Based Cell Motility and Cell Locomotion

Mitchison, T. J., & Cramer, L. P. (1996) · Cell · doi:10.1016/s0092-8674(00)81281-7 · Cited by 1,538 · see citing works

Identification and Functional Characterization of Brainstem Cannabinoid CB₂Receptors

Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470 · see citing works

Brain monoglyceride lipase participating in endocannabinoid inactivation

Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373 · see citing works

Characterization of ameboid microglia isolated from developing mammalian brain

Giulian, D., & Baker, T. J. (1986) · Journal of Neuroscience · doi:10.1523/jneurosci.06-08-02163.1986 · Cited by 1,300 · see citing works

Acanthamoeba spp. as Agents of Disease in Humans

Marciano‐Cabral, F., & Cabral, G. A. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.273-307.2003 · Cited by 1,293 · see citing works

N-formylmethionyl peptides as chemoattractants for leucocytes.

Schiffmann, E., Corcoran, B. A., & Wahl, S. M. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.3.1059 · Cited by 889 · see citing works

The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease

Selkoe, D. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01363-4 · Cited by 862 · see citing works

Chemokine receptors and their role in inflammation and infectious diseases

Murdoch, C., & Finn, A. H. R. (2000) · Blood · doi:10.1182/blood.v95.10.3032 · Cited by 841 · see citing works

Cannabinoid CB2 receptors: immunohistochemical localization in rat brain

Gong, J.-P., Onaivi, E. S., Ishiguro, H., Liu, Q.-R., Tagliaferro, P. A., Brusco, A., & Uhl, G. R. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.035 · Cited by 820 · see citing works

Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition

Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997) · Science · doi:10.1126/science.277.5329.1094 · Cited by 813 · see citing works

Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation

Ramírez, B. G., Blázquez, C., del Pulgar, T. G., Guzmán, M., & CEBALLOS, M. L. D. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4540-04.2005 · Cited by 783 · see citing works

The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

Smart, D., Gunthorpe, M. J., Jerman, J. C., Nasir, S., Gray, J., Muir, A. I., Chambers, J. K., Randall, A. D., & Davis, J. B. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703050 · Cited by 775 · see citing works

PLATELET ACTIVATING FACTOR: A BIOLOGICALLY ACTIVE PHOSPHOGLYCERIDE

Hanahan, D. J. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.002411 · Cited by 774 · see citing works

Cannabinoid-based drugs as anti-inflammatory therapeutics

Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728 · cited 10× · see citing works

GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current

Lauckner, J. E., Jensen, J. B., Chen, H.-Y., Lu, H., Hille, B., & Mackie, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711278105 · Cited by 710 · see citing works

Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration

Walter, L. M., Franklin, A. A., Witting, A., Wade, C. B., Xie, Y., Kunos, G., Mackie, K., & Stella, N. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01398.2003 · Cited by 666 · see citing works

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

Facci, L., Dal Toso, R., Romanello, S., Buriani, A., Skaper, S. D., & Leon, A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3376 · Cited by 632 · see citing works

Cannabinoid CB2Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains

Benito, C., Núñez, E., Tolón, R. M., Carrier, E. J., Rábano, A., Hillard, C. J., & Romero, J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11136.2003 · Cited by 624 · see citing works

Anandamide and vanilloid TRPV1 receptors

Ross, R. A. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705467 · Cited by 603 · see citing works

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

Járai, Z., Wagner, J. A., Varga, K., Lake, K. D., Compton, D. M., Martin, B. R., Zimmer, A. M., Bonner, T. I., Buckley, N. E., Mezey, É., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14136 · Cited by 598 · see citing works

Presynaptic Inhibition Caused by Retrograde Signal from Metabotropic Glutamate to Cannabinoid Receptors

Maejima, T., Hashimoto, K., Yoshida, T., Aiba, A., & Kano, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00375-0 · Cited by 556 · see citing works

Discovery of the Presence and Functional Expression of Cannabinoid CB2 Receptors in Brain

Onaivi, E. S., Ishiguro, H., GONG, J., Sejal, P., Perchuk, A., Meozzi, P. A., MYERS, L., Mora, Z., Tagliaferro, P. A., Gardner, E., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.052 · Cited by 546 · see citing works

Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor

Buckley, N. E., McCoy, K. L., Mezey, É., Bonner, T. I., Zimmer, A. M., Felder, C. C., Glass, M., & Zimmer, A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00211-9 · Cited by 544 · see citing works

Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain

Breivogel, C. S., Griffin, G., Marzo, V. D., & Martin, B. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.155 · Cited by 540 · see citing works

Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis

Benveniste, E. N. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050101 · Cited by 532 · see citing works

COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord

Yiangou, Y., Facer, P., Durrenberger, P., Chessell, I. P., Naylor, A., Bountra, C., Banati, R. R., & Anand, P. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-12 · Cited by 509 · see citing works

Modulation of the cannabinoid CB 2 receptor in microglial cells in response to inflammatory stimuli

Maresz, K., Carrier, E. J., Ponomarev, E. D., Hillard, C. J., & Dittel, B. N. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03380.x · Cited by 483 · see citing works

Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs.

Howlett, A. C., Qualy, J. M., & Khachatrian, L. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10219-8 · Cited by 470 · see citing works

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice

Steffens, S., Veillard, N. R., Arnaud, C., Pelli, G., Burger, F., Staub, C., Zimmer, A. D., Frossard, J., & Mach, F. (2005) · Nature · doi:10.1038/nature03389 · Cited by 469 · see citing works

Cannabinoid signalling

Demuth, D. G., & Molleman, A. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.055 · Cited by 423 · see citing works

Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models

Zhang, J., Hoffert, C., Vu, H. K., Groblewski, T., Ahmad, S., & O'Donnell, D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02704.x · Cited by 419 · see citing works

C5A Anaphylatoxin and Its Seven Transmembrane-Segment Receptor

Gerard, C. J., & Gerard, N. P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.004015 · Cited by 417 · see citing works

Levels, Metabolism, and Pharmacological Activity of Anandamide in CB1 Cannabinoid Receptor Knockout Mice

Marzo, V. D., Breivogel, C. S., Tao, Q., Bridgen, D. T., Razdan, R. K., Zimmer, A. M., Zimmer, A., & Martin, B. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752434.x · Cited by 389 · see citing works

Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation

Ehrhart, J. C., Obregon, D. F., Mori, T., Hou, H., Sun, N., Bai, Y., Klein, T., Fernandez, F., Tan, J., & Shytle, R. D. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-29 · Cited by 379 · see citing works

Identification and cloning of three novel human G protein-coupled receptor genes GPR52, ΨGPR53 and GPR55: GPR55 is extensively expressed in human brain

Sawzdargo, M., Nguyen, T., Lee, D. K., Lynch, K. R., Cheng, R., Heng, H. H., George, S. R., & O’Dowd, B. F. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00277-0 · Cited by 378 · see citing works

Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes.

Howlett, A. C., & Fleming, R. M. (1984) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15066-9 · Cited by 376 · see citing works

Perivascular Macrophages Are the Primary Cell Type Productively Infected by Simian Immunodeficiency Virus in the Brains of Macaques

Williams, K. C., Corey, S. M., Westmoreland, S. V., Pauley, D. R., Knight, H., deBakker, C. D., Alvarez, X. A., & Lackner, A. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.8.905 · Cited by 371 · see citing works

Cannabinoid‐receptor expression in human leukocytes

Bouaboula, M., Rinaldi, M. L., CARAYON, P., Carillon, C., Delpech, B., Shire, D. J., Fur, G. L., & Casellas, P. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17910.x · Cited by 367 · see citing works

Cannabinoid CB2 receptor: a new target for controlling neural cell survival?

Fernández‐Ruíz, J., Romero, J., Velasco, G., Tolón, R. M., Ramos, J. A., & Guzmán, M. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.11.001 · Cited by 362 · see citing works

Cannabinoid Receptors CB1 and CB2: A Characterization of Expression and Adenylate Cyclase Modulation within the Immune System

Schatz, A. R., Lee, M., Condie, R. B., Pulaski, J. T., & Kaminski, N. E. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8034 · Cited by 359 · see citing works

In silico patent searching reveals a new cannabinoid receptor

Baker, D., Pryce, G., Davies, W. I. L., & Hiley, C. R. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.003 · Cited by 347 · see citing works

CB2receptors in the brain: role in central immune function

Cabral, G. A., Raborn, E. S., Griffin, L., Dennis, J., & Marciano‐Cabral, F. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707584 · Cited by 346 · see citing works

Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation

Carlisle, S. J., Marciano‐Cabral, F., Staab, A., LUDWICK, C., & Cabral, G. A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00147-3 · Cited by 344 · see citing works

Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-α inhibitor and an effective neuroprotectant

Shohami, E., Gallily, R., Mechoulam, R., Bass, R., & Ben‐Hur, T. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00181-6 · Cited by 337 · see citing works

The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration

Ashton, J. C., & Glass, M. (2007) · Current Neuropharmacology · doi:10.2174/157015907780866884 · Cited by 336 · see citing works

Cultured Rat Microglial Cells Synthesize the Endocannabinoid 2-Arachidonylglycerol, Which Increases Proliferation via a CB2 Receptor-Dependent Mechanism

Carrier, E. J., Kearn, C. S., Barkmeier, A. J., Breese, N. M., Yang, W., Nithipatikom, K., Pfister, S. L., Campbell, W. B., & Hillard, C. J. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.999 · Cited by 336 · see citing works

Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study

Núñez, E., Benito, C., Pazos, M. R., Barbáchano, A., Fajardo, O., González, S. R., Tolón, R. M., & Romero, J. (2004) · Synapse · doi:10.1002/syn.20050 · Cited by 334 · see citing works

Motor neuron disease.

Leigh, P. N., & Chaudhuri, К. R. (1994) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.8.886 · Cited by 329 · see citing works

Molecular mechanisms of signal transduction in macrophages

Hamilton, T. A., & Adams, D. O. (1987) · Immunology Today · doi:10.1016/0167-5699(87)90145-9 · Cited by 327 · see citing works

A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation

Dinh, T. P., Freund, T. F., & Piomelli, D. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00150-0 · Cited by 319 · see citing works

Therapeutic Action of Cannabinoids in a Murine Model of Multiple Sclerosis

Arévalo‐Martín, Á., Vela, J. M., Molina‐Holgado, E., Borrell, J. I., & Guaza, C. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02511.2003 · Cited by 314 · see citing works

Chemokines and chemokine receptors: their manifold roles in homeostasis and disease.

Le, Y., Zhou, Y., Iribarren, P., & Wang, J. (2004) · PubMed · Cited by 307 · see citing works

Biosynthesis and inactivation of the endocannabinoid 2‐arachidonoylglycerol in circulating and tumoral macrophages

Marzo, V. D., Bisogno, T., PETROCELLIS, L. D., Melck, D. J., Orlando, P., Wagner, J. A., & Kunos, G. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00631.x · Cited by 296 · see citing works

Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains.

Westlake, T. M., Howlett, A., Bonner, T., Matsuda, L., & Herkenham, M. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90511-8 · Cited by 290 · see citing works

Signaling Pathway Associated with Stimulation of CB2 Peripheral Cannabinoid Receptor

Bouaboula, M., Poinot‐Chazel, C., Marchand, J., Canat, X., Bourrié, B., Rinaldi, M. L., Calandra, B., Fur, G. L., & Casellas, P. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0704p.x · Cited by 285 · see citing works

Multiple Sclerosis: Remyelination in Acute Lesions

Raine, C. S., & WU, E. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199305000-00003 · Cited by 285 · see citing works

Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids.

Lynn, A. B., & Herkenham, M. A. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38654-4 · Cited by 278 · see citing works

Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes.

Goldman, D. W., & Goetzl, E. J. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.4.1600 · Cited by 259 · see citing works

Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes.

Howlett, A. C. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12377-8 · Cited by 257 · see citing works

Cannabinoid CB₁and CB₂Receptors and Fatty Acid Amide Hydrolase Are Specific Markers of Plaque Cell Subtypes in Human Multiple Sclerosis

Benito, C., Romero, J. P., Tolón, R. M., Clemente, D., Docagne, F., Hillard, C. J., Guaza, C., & Romero, J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4814-06.2007 · Cited by 256 · see citing works

Δ-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway

Zhu, L. X., Sharma, S. P., Stolina, M., Gardner, B. K., Roth, M. D., Tashkin, D. P., & Dubinett, S. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.373 · Cited by 250 · see citing works

Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation.

Kaminski, N. E., Abood, M. E., Kessler, F. K., Martin, B. R., & Schatz, A. R. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09130-8 · Cited by 248 · see citing works

Synthetic cannabinoid WIN55,212‐2 inhibits generation of inflammatory mediators by IL‐1β‐stimulated human astrocytes

Sheng, W. S., Hu, S., Min, X. M., Cabral, G. A., Lokensgard, J. R., & Peterson, P. K. (2004) · Glia · doi:10.1002/glia.20108 · Cited by 246 · see citing works

Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid‐type CB2 receptor

Klegeris, A., Bissonnette, C. J., & McGeer, P. L. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705304 · Cited by 244 · see citing works

GPR55: a new member of the cannabinoid receptor clan?

Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707464 · Cited by 241 · see citing works

Cannabinoid receptors in microglia of the central nervous system: immune functional relevance

Cabral, G. A., & Marciano‐Cabral, F. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0405216 · Cited by 240 · see citing works

Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system

Williams, K. C., Alvarez, X. A., & Lackner, A. A. (2001) · Glia · doi:10.1002/glia.1105 · Cited by 237 · see citing works

Cannabinoid receptors and immunity

Klein, T., Newton, C. A., & Friedman, H. P. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01300-0 · Cited by 235 · see citing works

Cellular signal transduction by anandamide and 2-arachidonoylglycerol

Howlett, A. C., & Mukhopadhyay, S. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00187-0 · Cited by 229 · see citing works

The Central Cannabinoid Receptor (CB1) Mediates Inhibition of Nitric Oxide Production by Rat Microglial Cells

Waksman, Y., Olson, J. M., Carlisle, S. J., & Cabral, G. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38093-0 · Cited by 223 · see citing works

The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling

Bayewitch, M. L., Avidor‐Reiss, T., Levy, R., Barg, J., Mechoulam, R., & Vogel, Z. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01207-u · Cited by 211 · see citing works

The CB2 cannabinoid agonist AM‐1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset

Shoemaker, J. L., Seely, K. A., Reed, R. L., Crow, J. P., & Prather, P. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04346.x · Cited by 208 · see citing works

Cloning and Pharmacological Characterization of the Rat CB2 Cannabinoid Receptor

Griffin, G., Tao, Q., & Abood, M. E. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35367-4 · Cited by 207 · see citing works

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212

Croxford, J. L., & Miller, S. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17652 · Cited by 195 · see citing works

Marijuana, immunity and infection

Klein, T., Friedman, H., & Specter, S. C. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00226-9 · Cited by 192 · see citing works

Role of Chemotaxis in Inflammation

Harris, H. (1954) · Physiological Reviews · doi:10.1152/physrev.1954.34.3.529 · Cited by 192 · see citing works

Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.

Slipetz, D. M., O’Neill, G. P., Favreau, L., Dufresne, C., Gallant, M., Gareau, Y., Guay, D., Labelle, M., & Metters, K. M. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10254-x · Cited by 191 · see citing works

Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation.

Jeon, Y. J., Yang, K. H., Pulaski, J. T., & Kaminski, N. E. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09237-5 · Cited by 190 · see citing works

Cloning and molecular characterization of the rat CB2 cannabinoid receptor

Brown, S. M., Wager‐Miller, J., & Mackie, K. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(02)00341-x · Cited by 190 · see citing works

Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors

Melck, D., Bisogno, T., De Petrocellis, L., Chuang, H.-H., Julius, D., Bifulco, M., & Di Marzo, V. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1105 · Cited by 188 · see citing works

Neuropsychobiological Evidence for the Functional Presence and Expression of Cannabinoid CB2 Receptors in the Brain

Onaivi, E. S. (2006) · Neuropsychobiology · doi:10.1159/000100778 · Cited by 187 · see citing works

Pro-inflammatory cytokines induce the transcription factors C/EBP? and C/EBP? in astrocytes

Cardinaux, J., Allaman, I., & Magistretti, P. J. (2000) · Glia · doi:10.1002/(sici)1098-1136(20000101)29:1 · Cited by 183 · see citing works

Modulation and Functional Involvement of CB2 Peripheral Cannabinoid Receptors During B-Cell Differentiation

Carayon, P., Marchand, J., Dussossoy, D., Derocq, J., Jbilo, O., Bord, A., Bouaboula, M., Galiègue, S., Mondière, P., Pénarier, G., et al. (1998) · Blood · doi:10.1182/blood.v92.10.3605 · Cited by 178 · see citing works

The CB2 Cannabinoid Receptor Controls Myeloid Progenitor Trafficking

Palazuelos, J., Davoust, N., Julien, B., Hatterer, E., Aguado, T., Mechoulam, R., Benito, C., Romero, J., Silva, A., Guzmán, M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707960200 · Cited by 168 · see citing works

A role for CXCL12 (SDF-1α) in the pathogenesis of multiple sclerosis: Regulation of CXCL12 expression in astrocytes by soluble myelin basic protein

Calderon, T. M., Eugenín, E. A., Lopez, L., Kumar, S. S., Hesselgesser, J., Raine, C. S., & Berman, J. W. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.05.003 · Cited by 168 · see citing works

Neuropathological Diagnosis of Alzheimer’s Disease: A Perspective from Longitudinal Clinicopathological Studies

Dickson, D. W. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00065-1 · Cited by 168 · see citing works

Cannabinoids enhance human B‐cell growth at low nanomolar concentrations

Derocq, J., Ségui, M., Marchand, J., Fur, G. L., & Casellas, P. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00746-v · Cited by 167 · see citing works

Influence of fatty acid ethanolamides and Δ9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells

Berdyshev, E. V., Boichot, E., Germain, N., Allain, N., Anger, J.-P., & Lagente, V. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01007-8 · Cited by 167 · see citing works

Receptor-independent actions of cannabinoids on cell membranes: Focus on endocannabinoids

Öz, M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.09.009 · Cited by 164 · see citing works

Increasing cannabinoid levels by pharmacological and genetic manipulation delays disease progression in SOD1 mice

Bilsland, L. G., Dick, J. R. T., Pryce, G., Petrosino, S., Marzo, V. D., Baker, D., & Greensmith, L. (2006) · The FASEB Journal · doi:10.1096/fj.05-4743fje · Cited by 164 · see citing works

A Glial Endogenous Cannabinoid System Is Upregulated in the Brains of Macaques with Simian Immunodeficiency Virus-Induced Encephalitis

Benito, C., Kim, W.-K., Chavarría, I., Hillard, C. J., Mackie, K., Tolón, R. M., Williams, K., & Romero, J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3923-04.2005 · Cited by 163 · see citing works

Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes

Saario, S. M., Savinainen, J. R., Laitinen, J. T., Järvinen, T., & Niemi, R. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.12.003 · Cited by 163 · see citing works

Vanilloid (Capsaicin) Receptors in Health and Disease

SZALLASI, A. (2002) · American Journal of Clinical Pathology · doi:10.1309/7ayy-vvh1-gqt5-j4r2 · Cited by 160 · see citing works

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212

Croxford, J. L., & Miller, S. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317652 · Cited by 160 · see citing works

Δ9-Tetrahydrocannabinol Treatment Suppresses Immunity and Early IFN-γ, IL-12, and IL-12 Receptor β2 Responses to Legionella pneumophila Infection

Klein, T., Newton, C. A., Nakachi, N., & Friedman, H. P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6461 · Cited by 159 · see citing works

Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol

Alberich-Jordà, M., Verbakel, S. E., Valk, P. J. M., Vankan, Y., Maccarrone, M., Finazzi-Agrò, A., Löwenberg, B., & Delwel, R. (2002) · Blood · doi:10.1182/blood.v99.8.2786 · Cited by 158 · see citing works

Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease

Cabral, G. A., & Pettit, D. A. D. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00227-0 · Cited by 151 · see citing works

Carrier-Mediated Uptake of the Endogenous Cannabinoid Anandamide in RBL-2H3 Cells

Rakhshan, F., Day, T. A., Blakely, R., & Barker, E. L. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35376-5 · Cited by 149 · see citing works

Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide‐induced nitric oxide release in astrocyte cultures

Molina‐Holgado, F., Molina‐Holgado, E., Guaza, C., & Rothwell, N. J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10165 · Cited by 148 · see citing works

HUMAN IMMUNODEFICIENCY VIRUS AND THE CENTRAL NERVOUS SYSTEM

Spencer, D. C., & Price, R. W. (1992) · Annual Review of Microbiology · doi:10.1146/annurev.mi.46.100192.003255 · Cited by 140 · see citing works

Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection

Newton, C., Klein, T., & Friedman, H. P. (1994) · Infection and Immunity · doi:10.1128/iai.62.9.4015-4020.1994 · Cited by 140 · see citing works

Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes

Joseph, J., Niggemann, B., Zaenker, K. S., & Entschladen, F. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0509-9 · Cited by 137 · see citing works

Role of Fatty Acid Amide Hydrolase in the Transport of the Endogenous Cannabinoid Anandamide

Day, T. A., Rakhshan, F., Deutsch, D. G., & Barker, E. L. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.6.1369 · Cited by 136 · see citing works

Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism

Kaminski, N. E., Koh, W. S., Yang, K. H., Lee, M., & Kessler, F. K. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90588-6 · Cited by 133 · see citing works

Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain

Ashton, J. C., Rahman, R. M. A., Nair, S. M., Sutherland, B. A., Glass, M., & Appleton, I. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.10.053 · Cited by 131 · see citing works

Advances in experimental medicine and biology

(1984) · International Journal of Biochemistry · doi:10.1016/0020-711x(84)90214-3 · Cited by 128 · see citing works

Anandamide initiates Ca2+ signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells

Zoratti, C., Kipmen‐Korgun, D., Osibow, K., Malli, R., & Graier, W. F. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705529 · Cited by 127 · see citing works

The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro

Sacerdote, P., Martucci, C., Vaccani, A., Bariselli, F., Panerai, A. E., Colombo, A., Parolaro, D., & Massi, P. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.10.003 · Cited by 126 · see citing works

In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors

Sacerdote, P., Massi, P., Panerai, A. E., & Parolaro, D. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00307-6 · Cited by 124 · see citing works

Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!

Grimsey, N. L., Goodfellow, C. E., Scotter, E. L., Dowie, M. J., Glass, M., & Graham, E. S. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.02.014 · Cited by 123 · see citing works

2-Arachidonoylglycerol Induces the Migration of HL-60 Cells Differentiated into Macrophage-like Cells and Human Peripheral Blood Monocytes through the Cannabinoid CB2 Receptor-dependent Mechanism

Kishimoto, S., Gokoh, M., Oka, S., Muramatsu, M., Kajiwara, T., Waku, K., & Sugiura, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301359200 · Cited by 122 · see citing works

Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus

Morahan, P. S., Klykken, P. C., Smith, S., Harris, L. S., & Munson, A. E. (1979) · Infection and Immunity · doi:10.1128/iai.23.3.670-674.1979 · Cited by 121 · see citing works

Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes

Ghosh, S. T., Preet, A., Groopman, J. E., & Ganju, R. K. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.01.005 · Cited by 120 · see citing works

Cannabinoid Inhibition of the Processing of Intact Lysozyme by Macrophages: Evidence for CB2 Receptor Participation

McCoy, K. L., Matveyeva, M., Carlisle, S. J., & Cabral, G. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38313-2 · Cited by 115 · see citing works

The peripheral cannabinoid receptor knockout mice: an update

Buckley, N. E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707527 · Cited by 112 · see citing works

Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation

Docagne, F., Muñetón‐Gómez, V. C., Clemente, D., Ali, C., Loría, F., Correa, F., Hernangómez, M., Mestre, L., Vivien, D., & Guaza, C. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.12.005 · Cited by 109 · see citing works

Effects on the Immune System

Cabral, G. A., & Staab, A. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-26573-2_13 · Cited by 108 · see citing works

The endogenous cannabinoid anandamide potentiates interleukin‐6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor‐mediated pathway

Molina‐Holgado, F., Molina‐Holgado, E., & Guaza, C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00851-5 · Cited by 108 · see citing works

Regulation of Peripheral Cannabinoid Receptor CB2Phosphorylation by the Inverse Agonist SR 144528

Bouaboula, M., Dussossoy, D., & Casellas, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20397 · Cited by 107 · see citing works

Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival

Weydt, P., Hong, S. Y., Witting, A., Möller, T., Stella, N., & Kliot, M. (2005) · Amyotrophic Lateral Sclerosis · doi:10.1080/14660820510030149 · Cited by 104 · see citing works

Anandamide, a Natural Ligand for the Peripheral Cannabinoid Receptor Is a Novel Synergistic Growth Factor for Hematopoietic Cells

Valk, P. J. M., Verbakel, S. E., Vankan, Y., Hol, S., Mancham, S., Ploemacher, R., Mayen, A. E. M., Löwenberg, B., & Delwel, R. (1997) · Blood · doi:10.1182/blood.v90.4.1448 · Cited by 103 · see citing works

Drugs of abuse and immune function

WATSON, R. R. (1990) · CRC Press eBooks · Cited by 101 · see citing works

Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes

Wiley, J. L., & Martin, B. R. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00146-9 · Cited by 100 · see citing works

Differential expression of cannabinoid CB2 receptor mRNA in mouse immune cell subpopulations and following B cell stimulation

Lee, S. F., Newton, C. A., Widen, R. E., Friedman, H. P., & Klein, T. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01122-0 · Cited by 98 · see citing works

Opposing Actions of Endocannabinoids on Cholangiocarcinoma Growth

DeMorrow, S., Glaser, S. S., Francis, H., Venter, J. K., Vaculin, B. T., Vaculin, S., & Alpini, G. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608238200 · Cited by 96 · see citing works

Elevated Inflammatory Markers in a Group of Amyotrophic Lateral Sclerosis Patients from Northern India

Babu, G. N., Kumar, A., Chandra, R., Puri, S. K., Kalita, J., & Misra, U. K. (2008) · Neurochemical Research · doi:10.1007/s11064-007-9564-x · Cited by 96 · see citing works

Chemokine-Chemokine Receptor Network in Immune Cell Trafficking

Kim, C. H. (2004) · Current Drug Targets - Immune Endocrine & Metabolic Disorders · doi:10.2174/1568008043339712 · Cited by 95 · see citing works

Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo

Klein, T., Kawakami, Y., Newton, C. A., & Friedman, H. P. (1991) · Journal of Toxicology and Environmental Health · doi:10.1080/15287399109531496 · Cited by 94 · see citing works

2-Arachidonoylglycerol, an Endogenous Cannabinoid Receptor Ligand, Induces Accelerated Production of Chemokines in HL-60 Cells

Kishimoto, S. (2004) · The Journal of Biochemistry · doi:10.1093/jb/mvh063 · Cited by 88 · see citing works

Identification of Endocannabinoids and Related Compounds in Human Fat Cells

Gonthier, M., Hoareau, L., Festy, F., Matias, I., Valenti, M., Bès-Houtmann, S., Rouch, C., Silva, C. R. D., Chesne, S., d’Hellencourt, C. L., et al. (2007) · Obesity · doi:10.1038/oby.2007.581 · Cited by 84 · see citing works

New Perspectives in the Studies on Endocannabinoid and Cannabis: Abnormal Behaviors Associate With CB1 Cannabinoid Receptor and Development of Therapeutic Application

Fujiwara, M., & Egashira, N. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fmj04003x2 · Cited by 80 · see citing works

Tetrahydrocannabinol inhibition of macrophage nitric oxide production

Coffey, R. G., Yamamoto, Y., Snella, E. M., & Pross, S. H. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00356-5 · Cited by 77 · see citing works

Relative involvement of cannabinoid CB1 and CB2 receptors in the Δ9-tetrahydrocannabinol-induced inhibition of natural killer activity

Massi, P., Fuzio, D., Viganò, D., Sacerdote, P., & Parolaro, D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00860-2 · Cited by 77 · see citing works

Lipids as bioeffectors in the immune system

Cabral, G. A. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.013 · Cited by 75 · see citing works

CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies

Arévalo‐Martín, Á., García‐Ovejero, D., Gómez, O., Rubio‐Araiz, A., Navarro‐Galve, B., Guaza, C., Molina‐Holgado, E., & Molina‐Holgado, F. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707466 · Cited by 74 · cited 1× · see citing works

Endocannabinoids in Neuroimmunology and Stress

Carrier, E. J., Patel, S., & Hillard, C. J. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/156800705774933023 · Cited by 72 · see citing works

The Cannabinoid Delta-9-tetrahydrocannabinol Mediates Inhibition of Macrophage Chemotaxis to RANTES/CCL5: Linkage to the CB2 Receptor

Raborn, E. S., Marciano‐Cabral, F., Buckley, N. E., Martin, B. R., & Cabral, G. A. (2007) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9077-z · Cited by 68 · see citing works

Chemoattractant Receptor Signaling and the Control of Lymphocyte Migration

Kehrl, J. H. (2006) · Immunologic Research · doi:10.1385/ir:34:3:211 · Cited by 68 · see citing works

Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries

Gauthier, K. M., Baewer, D. V., Hittner, S. B., Hillard, C. J., Nithipatikom, K., Reddy, D. S., Falck, J. R., & Campbell, W. B. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00537.2004 · Cited by 66 · see citing works

2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1

Stefano, G. B., Bilfinger, T. V., Rialas, C. M., & Deutsch, D. G. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0702 · Cited by 64 · see citing works

Cannabinoid-mediated Inhibition of Inducible Nitric Oxide Production by Rat Microglial Cells: Evidence for CB1 Receptor Participation

Cabral, G. A., Harmon, K. W. N., & Carlisle, S. J. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47611-8_24 · Cited by 61 · see citing works

Distinct chemokinetic and chemotactic responses in neutrophil granulocytes

Keller, H. U., Wissler, J. H., Hess, M. W., & Cottier, H. (1978) · European Journal of Immunology · doi:10.1002/eji.1830080102 · Cited by 61 · see citing works

Effects of bacterial lipopolysaccharide on protein synthesis in murine peritoneal macrophages: Relationship to activation for macrophage tumoricidal function

Hamilton, T. A., Jansen, M., Somers, S. D., & Adams, D. O. (1986) · Journal of Cellular Physiology · doi:10.1002/jcp.1041280103 · Cited by 58 · see citing works

R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: Partial involvement of the CB2 receptor

Sánchez, A., González-Pérez, P., Galve‐Roperh, I., & García‐Merino, A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.018 · Cited by 56 · see citing works

Experimental Autoimmune Encephalomyelitis (EAE)

Racke, M. K. (2001) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0907s14 · Cited by 55 · see citing works

Expression of the CB1 cannabinoid receptor in macrophage-like cells from brain tissue: immunochemical characterization by fusion protein antibodies

Sinha, D., Bonner, T. I., Bhat, N. R., & Matsuda, L. A. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00181-1 · Cited by 55 · see citing works

Immune control by endocannabinoids — New mechanisms of neuroprotection?

Ullrich, O., Merker, K., Timm, J., & Tauber, S. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.018 · Cited by 51 · see citing works

The endocannabinoid system modulates a transient TNF pathway that induces neural stem cell proliferation

Rubio‐Araiz, A., Arévalo‐Martín, Á., Gómez, O., Navarro‐Galve, B., García‐Ovejero, D., Suetterlin, P., Sánchez-Heras, E., Molina‐Holgado, E., & Molina‐Holgado, F. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.03.010 · Cited by 50 · see citing works

Distinct Expression Profiles of the Peripheral Cannabinoid Receptor in Lymphoid Tissues Depending on Receptor Activation Status

Rayman, N., Lam, K. H., Laman, J. D., Simons, P. J., Löwenberg, B., Sonneveld, P., & Delwel, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2111 · Cited by 49 · see citing works

Differential Inhibition of RAW264.7 Macrophage Tumoricidal Activity by 9Tetrahydrocannabinol

Burnette-Curley, D., & Cabral, G. A. (1995) · Experimental Biology and Medicine · doi:10.3181/00379727-210-43926 · Cited by 48 · see citing works

Cannabis and recurrent herpes simplex.

Juel‐Jensen, B. E. (1972) · BMJ · doi:10.1136/bmj.4.5835.296-a · Cited by 46 · see citing works

Cannabinoid-mediated exacerbation of brain infection by opportunistic amebae

Cabral, G. A., & Marciano‐Cabral, F. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.027 · Cited by 45 · see citing works

Delta-9-tetrahydrocannabinol inhibits cell contact-dependent cytotoxicity of bacillus calmétte-guérin-activated macrophages

Burnette-Curley, D., Marciano‐Cabral, F., Fischer‐Stenger, K., & Cabral, G. A. (1993) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(93)90048-4 · Cited by 41 · see citing works

Influence of Marijuana Components (THC and CBD) on Human Mononuclear Cell Cytokine Secretion In vitro

Watzl, B., Scuderi, P., & WATSON, R. R. (1991) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5925-8_7 · Cited by 39 · see citing works

Methanandamide increases COX‐2 expression and tumor growth in murine lung cancer

Gardner, B. K., Zhu, L. X., Sharma, S. P., Tashkin, D. P., & Dubinett, S. M. (2003) · The FASEB Journal · doi:10.1096/fj.03-0254fje · Cited by 39 · see citing works

Moving toward understanding eukaryotic chemotaxis

Jin, T., & Hereld, D. (2006) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2006.04.008 · Cited by 39 · see citing works

R(+)-methanandamide-induced cyclooxygenase-2 expression in H4 human neuroglioma cells: possible involvement of membrane lipid rafts

Hinz, B., Ramer, R., Eichele, K., Weinzierl, U., & Brune, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.095 · Cited by 36 · see citing works

Stimulated neutrophil locomotion: chemokinesis and chemotaxis.

Becker, E. L. (1977) · PubMed · Cited by 36 · see citing works

In vivo imaging of the brain cannabinoid receptor

Gifford, A. N., Makriyannis, A., Volkow, N. D., & Gatley, S. J. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00148-2 · Cited by 34 · see citing works

Delta‐9‐tetrahydrocannabinol inhibits macrophage protein expression in response to bacterial immunomodulators

Cabral, G. A., & Mishkin, E. M. (1989) · Journal of Toxicology and Environmental Health · doi:10.1080/15287398909531243 · Cited by 34 · see citing works

EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors

Nowak, G., Arnt, J., & Hyttel, J. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90621-8 · Cited by 28 · see citing works

Modulation of Interleukin 2 Activity by 9-Tetrahydrocannabinol after Stimulation with Concanavalin A, Phytohemagglutinin, or Anti-CD3 Antibody

Nakano, Y., Pross, S. H., & Friedman, H. P. (1992) · Experimental Biology and Medicine · doi:10.3181/00379727-201-43494c · Cited by 24 · see citing works

Immunosuppression by Marijuana and Components

Friedman, H. P., Klein, T., & Specter, S. C. (1991) · Elsevier eBooks · doi:10.1016/b978-0-12-043780-1.50041-5 · Cited by 22 · see citing works

Delta‐9‐Tetrahydrocannabinol (THC), the Major Psychoactive Component of Marijuana, Exacerbates Brain Infection by Acanthamoeba

Marciano‐Cabral, F., Ferguson, T., Bradley, S. G., & Cabral, G. A. (2001) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.2001.tb00433.x · Cited by 21 · see citing works

Chemotaxis of monocytes.

Harris, H. (1953) · PubMed · Cited by 19 · see citing works

Downregulation of Cannabinoid Receptor 2 (CB2) Messenger RNA Expression During In Vitro Stimulation of Murine Splenocytes with Lipopolysaccharide

Lee, S. F., Newton, C. A., Widen, R. E., Friedman, H. P., & Klein, T. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47611-8_26 · Cited by 18 · see citing works

Tetrahydrocannabinol treatment suppresses growth restriction of Legionella pneumophila in murine macrophage cultures

Arata, S., Klein, T. W., Newton, C. A., & Friedman, H. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90590-8 · Cited by 18 · see citing works

Enhanced Growth of Legionella pneumophila in Tetrahydrocannabinol-Treated Macrophages

Arata, S., Newton, C., Klein, T., & Friedman, H. (1992) · Experimental Biology and Medicine · doi:10.3181/00379727-199-43330 · Cited by 16 · see citing works

Avoidance of Aβ[25-35] / (H2O2) -Induced Apoptosis in Lymphocytes by the Cannabinoid Agonists CP55, 940 and JWH-015 via Receptor-Independent and PI3K-Dependent Mechanisms: Role of NF- κB and p53

Velez‐Pardo, C., & Jiménez-Del-Río, M. (2006) · Medicinal Chemistry · doi:10.2174/157340606778250171 · Cited by 15 · see citing works

Diseases of the Nervous System.

(1935) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1935.02250130247018 · Cited by 14 · see citing works

Evidencias en favor de una pérdida axonal primaria en la esclerosis múltiple

Anthony, D. C., Hughes, P. M., & Perry, V. H. (2000) · Revista de Neurología · doi:10.33588/rn.3012.99548 · Cited by 10 · see citing works

Diseases of the Nervous System

Asbury, A. K., McKhann, G. M., McDonald, W. I., & Goadsby, P. J. (2004) · Cited by 7 · see citing works

Matrix Metalloproteinases Exhibit Different Expression Patterns in Inflammatory Demyelinating Diseases of the Central and Peripheral Nervous System

Kieseier, B. C., Clements, J. M., Gearing, A. J. H., & Hartung, H. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07729.x · Cited by 6 · see citing works

Amide Bond Bioisosteres: Strategies, Synthesis, and Successes

Kumari, S., Carmona, A. V., Tiwari, A. K., & Trippier, P. C. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00530 · Cited by 688 · see citing works

CB2: a cannabinoid receptor with an identity crisis

Atwood, B. K., & Mackie, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00729.x · Cited by 633 · see citing works

The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors

Marrs, W., Blankman, J. L., Horne, E. A., Thomazeau, A., Lin, Y. H., Coy, J. W., Bodor, Á. L., Muccioli, G. G., Hu, S. S., Woodruff, G., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2601 · Cited by 442 · see citing works

Plant derived substances with anti-cancer activity: from folklore to practice

Fridlender, M., Kapulnik, Y., & Koltai, H. (2015) · Frontiers in Plant Science · doi:10.3389/fpls.2015.00799 · Cited by 421 · see citing works

Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs

Gamble, L.-J., Boesch, J. M., Frye, C. W., Schwark, W. S., Mann, S., Wolfe, L. M., Brown, H., Berthelsen, E. S., & Wakshlag, J. J. (2018) · Frontiers in Veterinary Science · doi:10.3389/fvets.2018.00165 · Cited by 354 · see citing works

Phytocannabinoids as novel therapeutic agents in {CNS} disorders.

Hill, A. J., Williams, C. M., Whalley, B. J., & Stephens, G. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.002 · Cited by 312 · see citing works

The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain

Donvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301 · see citing works

Therapeutic Potential of Volatile Terpenes and Terpenoids from Forests for Inflammatory Diseases

Kim, T., Song, B., Cho, K. S., & Lee, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062187 · Cited by 282 · see citing works

Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice

Louvet, A., Teixeira-Clerc, F., Chobert, M.-N., Deveaux, V., Pavoine, C., Zimmer, A., Pecker, F., Mallat, A., & Lotersztajn, S. (2011) · Hepatology · doi:10.1002/hep.24524 · Cited by 260 · see citing works

Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease

O’Sullivan, S. E., & Kendall, D. A. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.09.007 · Cited by 247 · see citing works

Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic

Aso, E., & Ferrer, I. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00037 · Cited by 239 · see citing works

Activation of Cannabinoid Receptor 2 Attenuates Leukocyte–Endothelial Cell Interactions and Blood–Brain Barrier Dysfunction under Inflammatory Conditions

Ramirez, S. H., Haskó, J., Skuba, A., Fan, S., Dykstra, H., McCormick, R. C., Reichenbach, N. L., Krizbai, I. A., Mahadevan, A., Zhang, M., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4628-11.2012 · Cited by 238 · see citing works

Bioactive lipid mediators in skin inflammation and immunity

Kendall, A. C., & Nicolaou, A. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.10.003 · Cited by 229 · see citing works

Endocannabinoids drive the acquisition of an alternative phenotype in microglia

Mecha, M., Feliú, A., Carrillo-Salinas, F. J., Rueda-Zubiaurre, A., Ortega-Gutiérrez, S., de Sola, R. G., & Guaza, C. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.06.002 · Cited by 234 · see citing works

Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease

Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx073 · Cited by 226 · see citing works

2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain

Baggelaar, M. P., Maccarrone, M., & van der Stelt, M. (2018) · Progress in Lipid Research · doi:10.1016/j.plipres.2018.05.002 · Cited by 224 · see citing works

The Role of the Endocannabinoid System in Pain

Woodhams, S. G., Sagar, D. R., Burston, J. J., & Chapman, V. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-46450-2_7 · Cited by 205 · see citing works

Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target

Cassano, T., Calcagnini, S., Pace, L., Marco, F. D., Romano, A., & Gaetani, S. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00030 · Cited by 193 · see citing works

Brain Cannabinoid CB2 Receptor in Schizophrenia

Ishiguro, H., Horiuchi, Y., Ishikawa, M., Koga, M., Imai, K., Suzuki, Y., Morikawa, M., Inada, T., Watanabe, Y., Takahashi, M., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.024 · Cited by 184 · see citing works

CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity

Onaivi, E. S., Ishiguro, H., Gu, S., & Liu, Q. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111400652 · Cited by 184 · see citing works

The Highs and Lows of Cannabinoid Receptor Expression in Disease: Mechanisms and Their Therapeutic Implications

Miller, L. K., & Devi, L. A. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003491 · Cited by 178 · see citing works

Activation of Cannabinoid CB2 Receptor–Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury

Choi, I.-Y., Ju, C., Jalin, A. M. A. A., Lee, D. I., Prather, P. L., & Kim, W.-K. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.11.024 · Cited by 157 · see citing works

Functional Selectivity in CB2 Cannabinoid Receptor Signaling and Regulation: Implications for the Therapeutic Potential of CB2 Ligands

Atwood, B. K., Wager‐Miller, J., Haskins, C. P., Straiker, A. J., & Mackie, K. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.074013 · Cited by 152 · see citing works

A systematic review on the neuroprotective perspectives of beta‐caryophyllene

Machado, K. D. C., Islam, M. T., Ali, E. S., Rouf, R., Uddin, S. J., Dev, S., Shilpi, J. A., Shill, M. C., Reza, H. M., Das, A. K., et al. (2018) · Phytotherapy Research · doi:10.1002/ptr.6199 · Cited by 152 · see citing works

Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases

Haspula, D., & Clark, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207693 · Cited by 137 · see citing works

Endocannabinoid System Components as Potential Biomarkers in Psychiatry

Navarrete, F., García‐Gutiérrez, M. S., Barba, R. J., Rubio, G., Gasparyan, A., Austrich-Olivares, A., & Manzanares, J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00315 · Cited by 134 · see citing works

CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease

Aso, E., & Ferrer, I. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00243 · Cited by 131 · see citing works

Differential changes in GPR55 during microglial cell activation

Pietr, M., Kozela, E., Levy, R., Rimmerman, N., Lin, Y. H., Stella, N., Vogel, Z., & Juknat, A. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.05.028 · Cited by 130 · see citing works

Involvement of inflammation in Alzheimer’s disease pathogenesis and therapeutic potential of anti-inflammatory agents

Shadfar, S., Hwang, C. J., Lim, M., Choi, D., & Hong, J. T. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0648-x · Cited by 128 · see citing works

Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia

Navarro, G., Borroto‐Escuela, D. O., Angelats, E., Etayo, I., Reyes‐Resina, I., Pulido-Salgado, M., Rodriguez-Perez, A. I., Canela, E. I., Saura, J., Lanciego, J. L., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.08.015 · Cited by 127 · see citing works

Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids

Luchicchi, A., & Pistis, M. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8299-0 · Cited by 126 · see citing works

Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid-Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells

Juknat, A., Pietr, M., Kozela, E., Rimmerman, N., Levy, R., Gao, F., Coppola, G., Geschwind, D. H., & Vogel, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061462 · Cited by 117 · see citing works

Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and Neuroinflammation

Zoppi, S., Perez‐Nievas, B. G., Madrigal, J. L. M., Manzanares, J., Leza, J. C., & García‐Bueno, B. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.214 · Cited by 116 · see citing works

What we know and do not know about the cannabinoid receptor 2 (CB2)

Malfitano, A. M., Basu, S., Maresz, K., Bifulco, M., & Dittel, B. N. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.04.002 · Cited by 112 · see citing works

Cannabis in Sport

Huestis, M. A., Mazzoni, I. E., & Rabin, O. (2011) · Sports Medicine · doi:10.2165/11591430-000000000-00000 · Cited by 110 · see citing works

Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction

Panlilio, L. V., Justinová, Z., & Goldberg, S. R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.003 · Cited by 106 · see citing works

HIV-1 infection and alcohol abuse: Neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions

Persidsky, Y., Ho, W., Ramirez, S. H., Potula, R., Abood, M. E., Unterwald, E. M., & Tuma, R. F. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.001 · Cited by 106 · see citing works

A cannabinoid type 2 receptor agonist attenuates blood–brain barrier damage and neurodegeneration in a murine model of traumatic brain injury

Amenta, P. S., Jallo, J., Tuma, R. F., & Elliott, M. B. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23114 · Cited by 106 · see citing works

Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson’s Disease Induced by MPTP

Paredes, J. M. V., González-Castañeda, R. E., Gertsch, J., Chaparro-Huerta, V., López-Roa, R. I., Vázquez-Valls, E., Beas‐Zárate, C., Camins, A., & Flores-Soto, M. E. (2017) · Pharmaceuticals · doi:10.3390/ph10030060 · Cited by 109 · see citing works

Synthesis of Photoswitchable Δ9-Tetrahydrocannabinol Derivatives Enables Optical Control of Cannabinoid Receptor 1 Signaling

Westphal, M. V., Schafroth, M. A., Sarott, R. C., Imhof, M. A., Bold, C. P., Leippe, P., Dhopeshwarkar, A., Grandner, J. M., Katritch, V., Mackie, K., et al. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b06456 · Cited by 103 · see citing works

Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice

Verty, A. N. A., Stefanidis, A., McAinch, A. J., Hryciw, D. H., & Oldfield, B. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140592 · Cited by 103 · see citing works

The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer's Disease

Bedse, G., Romano, A., Lavecchia, A. M., Cassano, T., & Gaetani, S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141635 · Cited by 104 · see citing works

Cannabidiol as a potential treatment for psychosis

Schubart, C. D., Sommer, I. E., Fusar‐Poli, P., de Witte, L. D., Kahn, R. S., & Boks, M. P. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.11.002 · Cited by 100 · see citing works

Regulatory role of the cannabinoid CB2receptor in stress‐induced neuroinflammation in mice

Zoppi, S., Madrigal, J. L. M., Caso, J. R., García‐Gutiérrez, M. S., Manzanares, J., Leza, J. C., & García‐Bueno, B. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12607 · Cited by 99 · see citing works

The cannabinoid system and microglia in health and disease

Duffy, S. S., Hayes, J. P., Fiore, N. T., & Moalem‐Taylor, G. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108555 · Cited by 96 · see citing works

Mending the broken brain: neuroimmune interactions in neurogenesis

Molina‐Holgado, E., & Molina‐Holgado, F. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06849.x · Cited by 96 · see citing works

The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects

Kinsey, S. G., Mahadevan, A., Zhao, B., Sun, H., Naidu, P. S., Razdan, R. K., Selley, D. E., Damaj, M. I., & Lichtman, A. H. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.09.004 · Cited by 94 · see citing works

Modeling, Molecular Dynamics Simulation, and Mutation Validation for Structure of Cannabinoid Receptor 2 Based on Known Crystal Structures of GPCRs

Feng, Z., Alqarni, M. H., Yang, P., Tong, Q., Chowdhury, A., Wang, L., & Xie, X. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci5002718 · Cited by 94 · see citing works

Central and peripheral control of food intake

Abdalla, M. M. I. (2017) · Endocrine Regulations · doi:10.1515/enr-2017-0006 · Cited by 92 · see citing works

Activation of murine microglial N9 cells is attenuated through cannabinoid receptor CB2 signaling

Ma, L., Jia, J., Liu, X., Bai, F., Wang, Q., & Xiong, L. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.073 · Cited by 90 · see citing works

Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9‐tetrahydrocannabinol in BV‐2 microglial cells

Juknat, A., Pietr, M., Kozela, E., Rimmerman, N., Levy, R., Coppola, G., Geschwind, D. H., & Vogel, Z. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01461.x · Cited by 90 · see citing works

The constitutive production of the endocannabinoid 2‐arachidonoylglycerol participates in oligodendrocyte differentiation

Gómez, O., Arévalo‐Martín, Á., García‐Ovejero, D., Ortega‐Gutiérrez, S., Cisneros, J. A., Almazán, G., Sanchez-Rodriguez, M. A., Molina‐Holgado, F., & Molina‐Holgado, E. (2010) · Glia · doi:10.1002/glia.21061 · Cited by 90 · see citing works

Association of Pertussis Toxin with Severe Pertussis Disease

Scanlon, K. M., Skerry, C. M., & Carbonetti, N. H. (2019) · Toxins · doi:10.3390/toxins11070373 · Cited by 88 · see citing works

Latest advances in cannabinoid receptor agonists

Thakur, G. A., Tichkule, R. B., Bajaj, S., & Makriyannis, A. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770903436505 · Cited by 87 · see citing works

Functional Selectivity of CB2 Cannabinoid Receptor Ligands at a Canonical and Noncanonical Pathway

Dhopeshwarkar, A., & Mackie, K. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.232561 · Cited by 88 · see citing works

Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia

Guo, K., Mou, X., Huang, J., Xiong, N., & Li, H. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0243-5 · Cited by 85 · see citing works

Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury

Amenta, P. S., Jallo, J., Tuma, R. F., Hooper, D. C., & Elliott, M. B. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0191-6 · Cited by 82 · see citing works

HIV-infected cannabis users have lower circulating CD16+ monocytes and IFN-γ-inducible protein 10 levels compared with nonusing HIV patients

Rizzo, M. D., Crawford, R. B., Henriquez, J. E., Aldhamen, Y. A., Gulick, P. G., Amalfitano, A., & Kaminski, N. E. (2017) · AIDS · doi:10.1097/qad.0000000000001704 · Cited by 82 · see citing works

Marijuana-Derived Cannabinoids Trigger a CB2/PI3K Axis of Suppression of the Innate Response to Oral Pathogens

Gu, Z., Singh, S., Niyogi, R. G., Lamont, G. J., Wang, H., Lamont, R. J., & Scott, D. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02288 · Cited by 81 · see citing works

Selective Photoaffinity Probe That Enables Assessment of Cannabinoid CB2 Receptor Expression and Ligand Engagement in Human Cells

Soethoudt, M., Stolze, S. C., Westphal, M. V., van Stralen, L., Martella, A., van Rooden, E. J., Guba, W., Varga, Z. V., Deng, H., van Kasteren, S. I., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b11281 · Cited by 80 · see citing works

Evaluation of phytocannabinoids from high-potency Cannabis sativa using in vitro bioassays to determine structure–activity relationships for cannabinoid receptor 1 and cannabinoid receptor 2

Husni, A. S., McCurdy, C. R., Radwan, M. M., Ahmed, S. A., Slade, D., Ross, S. A., ElSohly, M. A., & Cutler, S. J. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-0972-6 · Cited by 79 · see citing works

The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review

Batalla, A., Janssen, H., Gangadin, S. S., & Bossong, M. G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071058 · Cited by 77 · see citing works

Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis

Campora, L., Miragliotta, V., Ricci, E., Cristino, L., Marzo, V. D., Albanese, F., della Valle, M. F., & Abramo, F. (2012) · American Journal of Veterinary Research · doi:10.2460/ajvr.73.7.988 · Cited by 81 · see citing works

Acute Effects of a Selective Cannabinoid-2 Receptor Agonist on Neuroinflammation in a Model of Traumatic Brain Injury

Elliott, M. B., Tuma, R. F., Amenta, P. S., Barbe, M. F., & Jallo, J. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2010.1672 · Cited by 77 · see citing works

Brain Innate Immunity in the Regulation of Neuroinflammation: Therapeutic Strategies by Modulating CD200-CD200R Interaction Involve the Cannabinoid System

Hernangómez, M., Carrillo-Salinas, F. J., Mecha, M., Correa, F., Mestre, L., Loría, F., Feliú, A., Docagne, F., & Guaza, C. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140130202911 · Cited by 77 · see citing works

Endocannabinoids: Effectors of glucocorticoid signaling

Balsevich, G., Petrie, G. N., & Hill, M. N. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.07.005 · Cited by 77 · see citing works

A Cannabinoid Receptor 2 Agonist Prevents Thrombin-Induced Blood–Brain Barrier Damage via the Inhibition of Microglial Activation and Matrix Metalloproteinase Expression in Rats

Li, L., Tao, Y., Tang, J., Chen, Q., Yang, Y., Feng, Z., Chen, Y., Yang, L. M., Yang, Y., Zhu, G., et al. (2015) · Translational Stroke Research · doi:10.1007/s12975-015-0425-7 · Cited by 72 · see citing works

A Systematic Review and Meta-Analysis on the Effects of Exercise on the Endocannabinoid System

Desai, S., Borg, B. A., Cuttler, C., Crombie, K. M., Rabinak, C. A., Hill, M. N., & Marusak, H. A. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0113 · Cited by 73 · see citing works

The endocannabinoid system modulates stress, emotionality, and inflammation

Crowe, M. S., Nass, S. R., Gabella, K. M., & Kinsey, S. G. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.007 · Cited by 72 · see citing works

The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: Evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells

Correa, F., Hernangómez, M., Mestre, L., Loría, F., Docagne, F., & Guaza, C. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.01.020 · Cited by 72 · see citing works

Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression

Zádor, F., Joca, S. R. L., Nagy-Grócz, G., Dvorácskó, S., Szűcs, E., Tömböly, C., Benyhe, S., & Vécsei, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115903 · Cited by 71 · see citing works

Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer’s Disease

Talarico, G., Trebbastoni, A., Bruno, G., & de Lena, C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180702144644 · Cited by 69 · see citing works

Cannabinoids in the Management of Acute Pain: A Systematic Review and Meta-analysis

Gazendam, A., Nucci, N. W., Gouveia, K., Khalik, H. A., Rubinger, L., & Johal, H. S. (2020) · Cannabis and Cannabinoid Research · doi:10.1089/can.2019.0079 · Cited by 68 · see citing works

Chemical and Physical Elicitation for Enhanced Cannabinoid Production in Cannabis

Gorelick, J., & Bernstein, N. (2017) · Springer eBooks · doi:10.1007/978-3-319-54564-6_21 · Cited by 68 · see citing works

Activation of CB2 receptor system restores cognitive capacity and hippocampal Sox2 expression in a transgenic mouse model of Alzheimer's disease

Wu, J., Hocevar, M., Foss, J. F., Bie, B., & Naguib, M. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.044 · Cited by 67 · see citing works

β-Caryophyllene (BCP) ameliorates MPP+ induced cytotoxicity

Wang, G., Ma, W., & Du, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.168 · Cited by 66 · see citing works

Preventive Effects of Dairy Products on Dementia and the Underlying Mechanisms

Ano, Y., & Nakayama, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071927 · Cited by 66 · see citing works

The Treatment of Cognitive, Behavioural and Motor Impairments from Brain Injury and Neurodegenerative Diseases through Cannabinoid System Modulation—Evidence from In Vivo Studies

Calina, D., Buga, A. M., Mitroi, M., Buha, A., Caruntu, C., Scheau, C., Bouyahya, A., El Omari, N., El Menyiy, N., & Docea, A. O. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082395 · Cited by 65 · see citing works

Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease

Nascimento, G. C., Ferrari, D. P., Guimarães, F. S., Bel, E. A. D., Bortolanza, M., & Ferreira‐Junior, N. C. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107808 · Cited by 67 · see citing works

Δ9-Tetrahydrocannabinol Suppresses Monocyte-Mediated Astrocyte Production of Monocyte Chemoattractant Protein 1 and Interleukin-6 in a Toll-Like Receptor 7–Stimulated Human Coculture

Rizzo, M. D., Crawford, R. B., Bach, A. P., Sermet, S., Amalfitano, A., & Kaminski, N. E. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.260661 · Cited by 61 · see citing works

Differential Activation of Intracellular versus Plasmalemmal CB2 Cannabinoid Receptors

Brailoiu, G. C., Deliu, E., Marcu, J. P., Hoffman, N. E., Console‐Bram, L., Zhao, P., Madesh, M., Abood, M. E., & Brailoiu, E. (2014) · Biochemistry · doi:10.1021/bi500632a · Cited by 61 · see citing works

Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation

Mastinu, A., Premoli, M., Ferrari‐Toninelli, G., Tambaro, S., Maccarinelli, G., Memo, M., & Bonini, S. A. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0013 · Cited by 60 · see citing works

The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: Implication for a novel molecular biomarker and future therapeutic intervention

Rossi, F., Bellini, G., Tolone, C., Luongo, L., Mancusi, S., Papparella, A., Sturgeon, C., Fasano, A., Nobili, B., Perrone, L., et al. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.03.011 · Cited by 60 · see citing works

Cannabinoids, the Heart of the Matter

Alfulaij, N., Meiners, F., Michalek, J., Small-Howard, A. L., Turner, H. C., & Stokes, A. J. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009099 · Cited by 59 · see citing works

Endocannabinoids, exercise, pain, and a path to health with aging

Watkins, B. A. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.10.001 · Cited by 59 · see citing works

Agonist-induced CXCR4 and CB2 Heterodimerization Inhibits Gα13/RhoA-mediated Migration

Scarlett, K. A., White, E. Z., Coke, C. J., Carter, J. R., Bryant, L. K., & Hinton, C. V. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0481 · Cited by 58 · see citing works

Endocannabinoid signaling in social functioning: an RDoC perspective

Karhson, D. S., Hardan, A. Y., & Parker, K. J. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.169 · Cited by 62 · see citing works

Cannabinoids for the treatment of dementia

Kuharić, D. B., Marković, D., Brković, T., Kegalj, M. J., Rubić, Ž., Vuica, A., Jerončić, A., & Puljak, L. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012820.pub2 · Cited by 55 · see citing works

Involvement of ERK1/2, cPLA2 and NF-κB in microglia suppression by cannabinoid receptor agonists and antagonists

Ribeiro, R., Wen, J., Li, S., & Zhang, Y. (2012) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2012.11.003 · Cited by 54 · see citing works

Cannabinoid Receptor 2 Protects against Acute Experimental Sepsis in Mice

Gui, H., Sun, Y., Luo, Z., Su, D., Dai, S., & Liu, X. (2013) · Mediators of Inflammation · doi:10.1155/2013/741303 · Cited by 53 · see citing works

Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide)

Hanlon, E. C. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104471 · Cited by 51 · see citing works

The Centenary of Immune Thrombocytopenia – Part 1: Revising Nomenclature and Pathogenesis

Consolini, R., Legitimo, A., & Caparello, M. C. (2016) · Frontiers in Pediatrics · doi:10.3389/fped.2016.00102 · Cited by 50 · see citing works

Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer’s Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway

Wang, L., Liu, B., Cao, Y., Xu, W., Sun, D., Li, M., Shi, F.-X., Li, M., Tian, Q., Wang, J., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0676-2 · Cited by 50 · see citing works

Cannabinoid Receptor Subtype 2 (CB2R) in a Multitarget Approach: Perspective of an Innovative Strategy in Cancer and Neurodegeneration

Mangiatordi, G. F., Intranuovo, F., Delre, P., Abatematteo, F. S., Abate, C., Niso, M., Creanza, T. M., Ancona, N., Stefanachi, A., & Contino, M. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01357 · Cited by 50 · see citing works

CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura

Rossi, F., Mancusi, S., Bellini, G., Roberti, D., Punzo, F., Vetrella, S., Matarese, S. M. R., Nobili, B., Maione, S., & Perrotta, S. (2011) · Haematologica · doi:10.3324/haematol.2011.045732 · Cited by 49 · see citing works

Cannabinoids in the descending pain modulatory circuit: Role in inflammation

Bouchet, C. A., & Ingram, S. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107495 · Cited by 51 · see citing works

The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential

Coelho, M., Duarte, P., Calado, M. S., Almeida, A. J., Reis, C. P., & Gaspar, M. M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121838 · Cited by 46 · see citing works

Cannabinoid Receptor-2 Ameliorates Inflammation in Murine Model of Crohn’s Disease

Leinwand, K. L., Jones, A., Huang, R. H., Jedlicka, P., Kao, D. J., de Zoeten, E. F., Ghosh, S., Moaddel, R., Wehkamp, J., Ostaff, M. J., et al. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx096 · Cited by 48 · see citing works

Emerging potential of cannabidiol in reversing proteinopathies

Dash, R., Ali, M. C., Jahan, I., Munni, Y. A., Mitra, S., Hannan, M. A., Timalsina, B., Oktaviani, D. F., Choi, H. J., & Moon, I. S. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101209 · Cited by 49 · see citing works

Cannabis dosing and administration for sleep: a systematic review

Velzeboer, R., Malas, A., Boerkoel, P., Cullen, K., Hawkins, M., Roesler, J., & Lai, W. W.-K. (2022) · SLEEP · doi:10.1093/sleep/zsac218 · Cited by 49 · see citing works

Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease

Basu, S., & Dittel, B. N. (2011) · Immunologic Research · doi:10.1007/s12026-011-8210-5 · Cited by 192 · see citing works

The CB2 receptor and its role as a regulator of inflammation

Turcotte, C., Blanchet, M., Laviolette, M., & Flamand, N. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2300-4 · Cited by 598 · see citing works

Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation

Rom, S., & Persidsky, Y. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9445-9 · Cited by 240 · see citing works

The Impact of the CB2 Cannabinoid Receptor in Inflammatory Diseases: An Update

Rakotoarivelo, V., Mayer, T. Z., Simard, M., Flamand, N., & Marzo, V. D. (2024) · Molecules · doi:10.3390/molecules29143381 · Cited by 69 · see citing works

MICROGLIAL CELL EXPRESSION OF THE TYPE 2 CANNABINOID RECEPTOR REGULATES IMMUNE-MEDIATED NEUROINFLAMMATIONPreprint

Moe, A. B., Rayasam, A., Sauber, G., Shah, R. K., Yuan, C.-Y., Szabó, A., Moore, B. M., Colonna, M., Cui, W., Romero, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.10.552854